School Observations of Children with Attention-Deficit Hyperactivity Disorder and Comorbid Tic Disorder: Effects of Methylphenidate Treatment

Journal of Developmental and Behavioral Pediatrics

Volumn 16, Issue 3, 1995, Pages 167-176

  Gadow, Kenneth D ^a   Nolan, Edith ^a   Sprafkin, Joyce ^a   Sverd, Jeffrey ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b Sagamore Children's Psychiat Center   (United States)

Author keywords

aggression; attention deficit hyperactivity disorder; methylphenidate; tic disorder; Tourette disorder

Indexed keywords

METHYLPHENIDATE;

AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT;

AGGRESSION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; TOURETTE SYNDROME;

EID: 0029316281     PISSN: 0196206X     EISSN: 15367312     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Comings DE, Comings BG: Tourette’s syndrome attention deficit disorder with hyperactivity: Are they genetically related? J Am Acad Child Adolesc Psychiatry 23:138–146, 1984.
2. Pauls DL, Hurst CR, Kruger SD, et al: Gilles de la Tourette’s syndrome and attention deficit disorder with hyperactivity: Evidence against a genetic relationship. Arch Gen Psychiatry 43:1177–1179, 1986.
3. Shapiro AK, Shapiro ES, Young JG, Feinberg TE: Gilles de la Tourette Syndrome, 2nd ed. New York, NY, Raven Press, 1988.
4. Pauls DL, Leckman JF, Cohen DJ: Familial relationship between Gilles de la Tourette’s syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 32:1044–1050, 1993.
5. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA: Stimulant medications precipitate Tourette’s syndrome. JAMA 247:1729–1731, 1982.
6. Burd L, Kerbeshian J: Treatment generated side effects from use of behavior modification in Tourette syndrome. Dev Med Child Neurol 29:831–832, 1987.
7. Shapiro E, Shapiro AK, Fulop G, et al: Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry 46:722–730, 1989.
8. Azrin NH, Peterson AL: Treatment of Tourette syndrome by habit reversal: A waiting-list control group comparison. Behav Ther 21:305–318, 1990.
9. Golden GS: Tics and Tourette syndrome. Hosp Pract(Off Ed) 14:91–93,96–97,100, 1979.
10. Shapiro AK, Shapiro E: Do stimulants provoke, cause or exacerbatetics and Tourette’s syndrome? Compr Psychiatry 22:265–273, 1981.
11. Gadow KD, Sverd J: Stimulants for ADHD in child patients with Tourette’s syndrome: The issue of relative risk. J Dev Behav Pediatr 11:269–271, 1990.
12. Sverd J, Gadow KD, Paolicelli LM: Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry 28:574–579, 1989.
13. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J: Motor/vocal tics compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Res 33:83–94, 1990.
14. Konkol RJ, Fischer M, Newby RF: Double-blind placebo-controlled stimulant trial in children with Tourette’s syndrome attention-deficit hyperactivity disorder [abstract]. Ann Neurol 28:424, 1990.
15. Gadow KD, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 31:462–471, 1992.
16. Sverd J, Gadow KD, Nolan EE, Sprafkin J, Ezor SN: Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations, in Chase TN, Friedhoff AJ, Cohen DJ (eds): Advances in Neurology, vol 58: Tourette Syndrome: Genetics, Neurobiology, and Treatment. New York, NY, Raven Press, 1992, pp 271–281.
17. Walkup JT: Stimulant treatment of attention deficit hyperactivity disorder in children and adolescents with Tourette disorder. AACAP NEWS 25:48–50, 1994.
18. Barkley RA: The ecological validity of laboratory and analogue assessment methods of ADHD symptoms. J Abnorm Child Psychol 19:149–178, 1991.
19. Nolan EE, Gadow KD, Sverd J: Observations and ratings of tics in school settings. J Abnorm Child Psychol 22:579–593, 1994.
20. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN: Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 52:444–455, 1995.
21. Friedhoff AJ: Receptor maturation in pathogenesis and treatment of Tourette syndrome, in Friedhoff JA, Chase TN (eds): Advances in Neurology, vol 35, Gilles de la Tourette Syndrome. New York, NY, Raven Press, 1982, pp 133–140.
22. Sprafkin J, Gadow KD: Four purported cases of methylphenidate-induced tic exacerbation: Methodological and clinical doubts. J Child Adolesc Psychopharmacol 3:231–244, 1993.
23. American Psychiatric Association: Diagnostic Statistical Manual of Mental Disorders, 3rd ed, Revised. Washington, DC, American Psychiatric Association Press, 1987.
24. Conners CK: Rating scales for use in drug studies with children (special issue: Pharmacotherapy of children). Psychopharmacol Bull 24–84:1973.
25. Loney J, Milich R: Hyperactivity inattention and aggression in clinical practice, in Wolraich M, Routh DK (eds): Advances in Developmental and Behavioral Pediatrics, vol 3. Greenwich, CT, JAI Press, 1982, pp 113–147.
26. Goyette CH, Conners CK, Ulrich RF: Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol 6:221–236, 1978.
27. Loney J: A short parent scale for subgrouping childhood hyperactivity and aggression. Presented at the annual meeting of the American Psychological Association, Toronto, Canada 1984.
28. Gadow KD, Sprafkin J: Manual for the Stony Brook Child Symptom Inventories. Stony Brook, NY, Checkmate Plus, 1994.
29. Grayson P, Carlson GA: The utility of a DSM-III-R-based checklist in screening child psychiatric patients. J Am Acad Child Adolesc Psychiatry 30:669–673, 1991.
30. Leckman JF, Riddle MA, Hardin MT, et al: The Yale Global Tic Severity Scale: Initial testing of a clinic-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566–573, 1989.
31. Leckman JF, Towbin KE, Ort SI, Cohen DJ: Clinical assessment of tic disorder severity, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette’s Syndrome and Tic Disorders, New York, NY, Wiley, 1988, pp 55–78.
32. Kurlan R, Riddle M, Como P: Tourette Syndrome Unified Rating Scale. Bayside, NY, Tourette Syndrome Association, 1988.
33. Roberts MA, Ray RS, Roberts RJ: A playroom observational procedure for assessing hyperactive boys. J Pediatr Psychol 9:177–191, 1984.
34. Milich R, Loney J, Landau S: Independent dimensions of hyperactivity and aggression: A validation with playroom observational data. J Abnorm Psychol 91:183–198, 1982.
35. Tourette Syndrome Workshop Committee on Classification, Rating Scales: Report of the Tourette Syndrome Workshop on Definitions of Tic Disorders, Fahn S (Chair), New York, May 20–21, 1988. Bayside, NY, Tourette Syndrome Association, 1988.
36. Kurlan R: Tourette’s syndrome: Current concepts. Neurology 39:1625–1630, 1989.
37. Gadow KD: A school-based medication evaluation program, in Matson JL (ed): Handbook of Hyperactivity in Children. Needham Heights, MA, Allyn & Bacon, 1993, pp 186–219.
38. Abikoff H, Gittelman R: Classroom Observation Code: A Modification of the Stony Brook Code. Psychopharmacol Bull 21:901–909, 1985.
39. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L: Methylphenidate in aggressive-hyperactive boys. I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 29:710–718, 1990.
40. Gittelman-Klein R, Klein DF, Abikoff H, et al: Relative efficacy of methylphenidate and behavior modification in hyperactive children: An interim report. J Abnorm Child Psychol 4:361–379, 1976.
41. Sprafkin J, Grayson P, Gadow KD, Nolan EE, Paolicelli LM: Code for Observing Social Activity. Stony Brook, NY, Department of Psychiatry, State University of New York, 1986.
42. Gadow KD, Nolan EE, Paolicelli LM, Sprafkin J: A procedure for assessing the effects of methylphenidate on hyperactive school children in public school settings. J Clin Child Psychol 20:268–276, 1991.
43. Abikoff H, Gittelman R, Klein DF: Classroom observation code for hyperactive children: A replication of validity. J Consult Clin Psychol 48:555–565, 1980.
44. Abikoff H, Gittelman R: The normalizing effects of methylphenidate on the classroom behavior of ADDH children. J Abnorm Child Psychol 13:33–44, 1985.
45. Hinshaw SP, Henker B, Whalen CK, Erhardt D, Dunnington RE: Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings. J Consult Clin Psychol 57:636–643, 1989.
46. Whalen CK, Henker B, Collins BE, Finck D, Dotemoto S: A social ecology of hyperactive boys: Medication effects in systematically structured classroom environments. J Appl Behav Anal 12:65–81, 1979.
47. Werry JS, Sprague RL: Methylphenidate in children: Effects of dosage. Aust N Z J Psychiatry 8:9–19, 1974.
48. Solanto MV: Behavioral effects of low-dose methylphenidate in childhood attention deficit disorder: Implications for a mechanism of stimulant drug action. J Am Acad Child Psychiatry 25:96–101, 1986.
49. Gadow KD: Prevalence of drug therapy, in Werry JS, Aman M (eds): Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. New York, NY, Plenum, 1993, pp 57–74.
50. Sprague RL, Sleator EK: What is the proper dose of stimulant drugs in children? Int J Mental Health 4:75–104, 1975.
51. Sprague RL, Sleator EK: Drugs and dosages: Implications for learning disabilities, in Knights RM, Bakker, DJ (eds): The Neuropsychology of Learning Disorders: Theoretical Approaches. Baltimore, MD, University Park Press, 1976, pp 351–366.
52. Sprague RL, Sleator EK: Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science 198:1274–1276, 1977.
53. Gadow KD, Paolicelli LM, Nolan EE, et al: Methylphenidate in aggressive hyperactive boys. II. Indirect effects of medication treatment on peer behavior. J Child Adolesc Psychopharmacology 2:49–61, 1992.
54. Douglas VI, Barr RG, Amin K, O’Neill ME, Britton BG: Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. J Child Psychol Psychiatry 29:453–475, 1988.
55. Rapport MD, Stoner G, DuPaul GJ, et al: Attention deficit disorder and methylphenidate: Multilevel analysis of dose-response effects on children’s impulsivity across settings. J Am Acad Child Adolesc Psychiatry 27:60–69, 1988.
56. Loney J, Kramer J, Milich RS: The hyperactive child grows up: Predictors of symptoms, delinquency and achievement at follow-up, in Gadow KD, Loney J (eds): Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, CO, Westview Press, 1981, pp 381–415.
57. Loney J, Whaley-Klahn MA, Rosier T, Conboy J: Hyperactive boys and their brothers at 21: Predictors of aggressive and antisocial outcomes, in Van Dusen KT, Mednick SA (eds): Prospective Studies of Crime and Delinquency. Boston, Kluwer-Nijhoff, 1983, pp 181–207.
58. Weiss G, Minde K, Werry JS, Douglas VI, Nemeth E: Studies on the hyperactive child. VIII. Five-year follow-up. Arch Gen Psychiatry 24:409–414, 1971.
59. Chappell PB, McSwiggan-Hardin MT, Scahill L, et al: Videotape tic counts in the assessment of Tourette’s syndrome: Stability, reliability, and validity. J Am Acad Child Adolesc Psychiatry 33:386–393, 1994.
60. Creager RO, Van Riper C: The effect of methylphenidate on the verbal productivity of children with cerebral dysfunction. J Speech Hear Res 10:623–628, 1967.
61. Ludlow CL, Rapoport JL, Bassich CJ, Mikkelsen EG: Differential effects of dextroamphetamine on language performance in hyperactive and normal boys, in Knights RM, Bakker DJ (eds): Treatment of Hyperactive and Learning Disordered Children, Baltimore, MD, University Park Press, 1980, pp 185–205.
62. Barkley RA, Cunningham CE, Karlsson J: The speech of hyperactive children and their mothers: Comparison with normal children and stimulant drug effects. J Learn Disabil 16:105–110, 1983.
63. Whalen CK, Collins BE, Henker B, et al: Behavior observations of hyperactive children and methylphenidate (Ritalin) effects in systematically structured classroom environments: Now you see them, now you don’t. J Pediatr Psychol 3:177–187, 1978.